NCT04852770

Efficacy of TBCT, MBHP and PPT for PTSD During the Covid-19 Pandemics

Terminated NA Last updated 4 April 2025

What this trial tests

NA trial testing Trial-Based Cognitive Therapy in Posttraumatic Stress Disorder in 135 participants. Terminated before completion.

Timeline

6 April 2020

Primary endpoint
21 June 2023

18 July 2023

Quick facts

Lead sponsor	Fundação Bahiana de Infectologia
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	135
Start date	6 April 2020
Primary completion	21 June 2023
Estimated completion	18 July 2023
Sites	3 locations across Brazil

Drugs / interventions tested

• Trial-Based Cognitive Therapy
• Mindfulness-Based Health Promotion
• Positive psychotherapy

Conditions studied

• Posttraumatic Stress Disorder — all drugs for Posttraumatic Stress Disorder →
• Covid19 — all drugs for Covid19 →

Sponsor

Fundação Bahiana de Infectologia — full company profile →

Who can join

Adults 18 to 60, any sex, with Posttraumatic Stress Disorder or Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The psychotherapies to be assessed in the present study, delivered on-line, are: trial-based cognitive therapy (TBCT), mindfulness-based health promotion (MBHP), and positive psychotherapy (PPT). Objectives: 1) to assess the efficacy of TBCT compared to MBHP and PPT in reducing the symptoms of PTSD during the COVID-19 pandemic.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. A Randomized Clinical Trial to Assess the Efficacy of Online-Treatment with Trial-Based Cognitive Therapy, Mindfulness-Based Health Promotion and Positive Psychotherapy for Post-Traumatic Stress Disorder during the COVID-19 Pandemic: A Study Protocol.
   Duran ÉP, Hemanny C, Vieira R, Nascimento O, et al · · 2022 · cited 5× · PMID 35055641 · DOI 10.3390/ijerph19020819